Ginsenoside Rk1

Ginsenoside Rk1 has been reported to inhibit the Jak2/Stat3 signaling pathway and the activation of NF-κB， with anti-tumor， anti-platelet aggregation， anti-inflammatory， and anti-insulin resistance activities.